CDK4 and liver cancer: Previous reports showed that 20(S)-Rh2 could reduce the transcriptional activity of E2F by targeting cyclin D1 and CdK4/6, leading to G1/S cell cycle arrest and apoptosis in liver cancer and breast cancer cells48.